Prof. Dr. Dolores Cahill is a renowned expert worldwide in high-throughput proteomics technology development and automation, high content protein arrays and their biomedical applications, including in biomarker discovery. Her team has achieved key breakthroughs in developing high-density protein and antibody array technologies and demonstrated their applications in biological and medical research. Prof. Cahill pioneered this research area at the Max Planck Institute of Molecular Genetics in Berlin, Germany, and holds several international patents in this vital field. She has received the prestigious BMBF BioFuture Award from the German Minister of Science, as well as the Federation of European Biochemical Societies 2009 Award, and co-founded Protagen AG to commercialize her discoveries. Prof. Cahill is Professor of Translational Science at the Conway Institute, School of Medicine and Medical Sciences at the University College Dublin.